News | Left Atrial Appendage (LAA) Occluders | July 26, 2023

Abbott Recalls Amplatzer Steerable Delivery Sheath for Increased Risk of Air Embolism

Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to be introduced into patients who have procedures with this device. 

Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to be introduced into patients who have procedures with this device.

July 26, 2023 — Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to be introduced into patients who have procedures with this device. Air embolism can lead to injuries such as sudden (acute) reduction in blood flow to the heart (indicated by ST elevation), fast or slow heartbeat (tachycardia or bradycardia), low blood pressure (hypotension), and lack of enough oxygen in the blood (desaturation). Air embolism can also potentially lead to serious health consequences including stroke and death. 

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death. 

Recalled Product  

  • Product Name: Amplatzer Steerable Delivery Sheath  
  • Product Model: ASDS-14F-075 
  • Distribution Dates: October 4, 2022 to February 22, 2023 
  • Devices Recalled in the U.S.: 672 
  • Date Initiated by Firm: June 12, 2023 

Device Use 

The Abbott Amplatzer Steerable Delivery Sheath is a cardiac catheter inserted through the skin that provides a pathway for catheter-based devices to be introduced into the chambers of the heart. It is specifically used to deliver the Amplatzer Amulet Left Atrial Appendage Occluder. 

Reason for Recall  

Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air bubbles (air emboli) to be introduced into patients who have procedures with this device.  

Air embolism can lead to injuries such as sudden (acute) reduction in blood flow to the heart (indicated by ST elevation), fast or slow heartbeat (tachycardia or bradycardia), low blood pressure (hypotension), and lack of enough oxygen in the blood (desaturation). Air embolism can also potentially lead to serious health consequences including stroke and death. 

Abbott reports 26 incidents, 16 injuries, and no deaths related to this issue.  

Who May be Affected  

  • People having cardiac catheterization procedures with the Abbott Steerable Delivery Sheath.  
  • Healthcare providers who planned to use the Abbott Steerable Delivery Sheath for cardiac catheterization.   

What to Do  

On June 12, 2023, Abbott issued a Medical Device Recall notice to customers. The communication provided the following recommended actions: 

  • Return any remaining unused Amplatzer Steerable Delivery Sheaths to Abbott. Abbott representatives can assist with return of these devices. 
  • Use the fixed curve TorqVue 45°x45° delivery system for future Amplatzer Amulet Left Atrial Appendage Occluder implants. 
  • Complete and return the acknowledgment form attached to the notice to Abbott. 

Contact Information  

Customers with questions about this recall should contact their local Abbott representative or Abbott Support at 1-800-544-1664 (Option 2).  

Additional Resources:  

Medical Device Recall Database Entry 

How do I report a problem? 

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program using the online form or call 1-800-332-1088 for more information on how to mail or fax the form. 


Related Content

News | FDA

Nov. 22, 2024 — BridgeBio Pharma, Inc. recently announced that the U.S. Food and Drug Administration (FDA) approved ...

Home November 25, 2024
Home
News | FDA

July 29, 2024 — CorVascular, a leading producer of peripheral arterial disease (PAD) / peripheral vascular disease (PVD) ...

Home July 29, 2024
Home
News | FDA

July 2, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abbott has issued a correction for its ...

Home July 02, 2024
Home
News | FDA

June 18, 2024 — Elixir Medical has announced the company’s novel bioadaptive implant, DynamX Sirolimus-Eluting Coronary ...

Home June 18, 2024
Home
News | FDA

June 17, 2024 — Elutia Inc., a pioneer in drug-eluting biomatrix products, today announced that its Antibiotic-Eluting ...

Home June 17, 2024
Home
News | FDA

June 13, 2024 — Xeltis, a leading developer of transformative implants that enable the natural creation of living and ...

Home June 13, 2024
Home
News | FDA

June 3, 2024 — Heuron, a specialized medical AI startup focused on brain and neurological disorders based in South Korea ...

Home June 03, 2024
Home
News | FDA

May 17, 2024 — Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has ...

Home May 17, 2024
Home
News | FDA

May 15, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abbott is recalling the HeartMate 3 LVAS by ...

Home May 15, 2024
Home
News | FDA

May 8, 2024 — The US Food and Drug Administration (FDA) is alerting health care providers and facilities about our ...

Home May 08, 2024
Home
Subscribe Now